Ilsung Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Ilsung Pharmaceuticals has a total shareholder equity of ₩382.8B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩419.2B and ₩36.4B respectively.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | n/a |
| Cash | ₩235.42b |
| Equity | ₩382.75b |
| Total liabilities | ₩36.44b |
| Total assets | ₩419.19b |
Recent financial health updates
No updates
Recent updates
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Feb 20
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?
Jan 16Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like
Dec 18
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Nov 21Financial Position Analysis
Short Term Liabilities: A003120's short term assets (₩293.9B) exceed its short term liabilities (₩34.9B).
Long Term Liabilities: A003120's short term assets (₩293.9B) exceed its long term liabilities (₩1.5B).
Debt to Equity History and Analysis
Debt Level: A003120 is debt free.
Reducing Debt: A003120 had no debt 5 years ago.
Debt Coverage: A003120 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A003120 has no debt, therefore coverage of interest payments is not a concern.